OPTIMIZING TRANSDERMAL PATCH FORMULATION FOR ENHANCED DELIVERY OF RIVAROXABAN: A COMPREHENSIVE DESIGN OF EXPERIMENTS APPROACH
DOI:
https://doi.org/10.22159/ijpps.2024v16i12.51075Keywords:
Rivaroxaban, Transdermal patches, Factorial design, in vitro drug release, hydroxypropylmethylcelluloseAbstract
Abstract:
Objective: To optimize transdermal patches of rivaroxaban (RXB) using polyvinylpyrolidine (PVP K30), hydroxypropylmethylcellulose (HPMC E50) as hydrophilic polymer, propylene glycol as plasticizer and permeation enhancer.
Methods: The TD patches were crafted through the solvent casting technique using 2-level, 3-factor factorial design. These patches underwent assessment for thickness, folding endurance, in vitro drug release, drug content, moisture uptake, and moisture loss. An 8-stage diffusion cell apparatus facilitated the in vitro drug release testing. Here the independent variables were HPMC E50, PVP K30, Propylene glycol. The change in the concentration of these independent variables results in the optimization of TD patch. The dependent variables are thickness, folding endurance, in vitro diffusion studies.
Results: The patches exhibited the desired properties. Propylene glycol enhanced the permeation of RXB. It shows that 94.58% of drug release was achieved in 24hrs.
Conclusion: Propylene glycol increased the release of RXB because it permeates through the membrane. Whereas, HPMC E50 has the high solubility. Thus, RXB transdermal patches were potentially suitable for transdermal drug delivery system.
Downloads
References
John L, Kumar A. Comparison of Amlodipine Transdermal Patches Using Hydroxypropyl methylcellulose and Chitosan. Asian J Pharm Clin Res. 2014 Jan 1;7(1):86-90.
Das A, Ahmed AB. Formulation and evaluation of transdermal patch of indomethacin containing patchouli oil as a natural penetration enhancer. Asian Journal of Pharmaceutical and Clinical Research. 2017 Aug;10(11):320-5.DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i11.20926
Evans VJ, Lawrence M, Whitley J, Johns C, Pillai S, Hawkins K, Power K, Morris K, Williams PR, Evans PA. The treatment effect of RXB on clot characteristics in patients who present acutely with first-time deep vein thrombosis. Clinical hemorheology and microcirculation. 2022 Jan 1;80(2):139-51.doi: 10.3233/CH-201030
Nadendla RR, Rao KS, Kanna S, Satyanarayana J, Mrudhvani C. Preparation and evaluation of spray dried powder of Trigonella foenum-graecum seeds as suspending agents to develop RXB nanosuspension. Indian Journal of Biochemistry and Biophysics (IJBB). 2024 Jan 29;61(2):105-17.DOI: https://doi.org/10.56042/ijbb.v61i2.6922
Kanna S, Nadendla RR, Satyanarayana J, Karthikeya V, Sonu MV, Bhargavi PN. Formulation and Evaluation of Fast-Dissolving Oral Film of RXB. Journal of Young Pharmacists. 2023 Dec 7;15(4):687-95. doi:10.5530/jyp.2023.15.94
Patel RP, Patel G, Patel H, Baria A. Formulation and evaluation of transdermal patch of aceclofenac. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009;1(2):108-15
Cherukuri S, Batchu UR, Mandava K, Cherukuri V, Ganapuram KR. Formulation and evaluation of transdermal drug delivery of topiramate. International journal of pharmaceutical investigation. 2017 Jan;7(1):10.doi: 10.4103/jphi.JPHI_35_16
Alam MI, Alam N, Singh V, Alam MS, Ali MS, Anwer T, Safhi MM. Type, preparation, and evaluation of transdermal patch: a review. World journal of pharmacy and pharmaceutical sciences. 2013 May 21;2(4):2199-233.
Kumar SS, Behury B, Sachinkumar P. Formulation and evaluation of transdermal patch of Stavudine. Dhaka University journal of Pharmaceutical sciences. 2013 Sep 2;12(1):63-9
Prashant M, Evaluation of polymerized rosin for the formulation and development of Transdermal drug delivery systems.AAPSPharmscitech. 2005; 6(4):48-53.DOI: https://doi.org/10.1208/pt060481
Zakir S, Banu SK, Fatima SN, Jahan T, Wajida F, Sireesha P, Roshan S, Mahammed NL. Formulation and evaluation of transdermal patches of Ketoprofin by using different polymers. Asian Journal of Pharmaceutical Research and Development. 2015 Nov-Dec; 3(6):1-11
Budhathoki U, Gartoulla K, Shakya S. Formulation and evaluation of transdermal patches of atenolol. Indonesian Journal of Pharmacy. 2016 Dec; 23;27(4):196
Yadav AV, Urade MN. Formulation and evaluation of chitosan based transdermal patches of lornoxicam for prolonged drug release and to study the effect of permeation enhancer. Indian J. Pharm. Educ. Res. 2019 Jan; 1(53):88-96.DOI: 10.5530/ijper.53.1.12
Kriplani P, Sharma A, Aman PP, Chopra B, Dhingra A, Deswal G. Formulation and evaluation of transdermal patch of diclofenac sodium. Global Journal of Pharmacy and Pharmaceutical Sciences. 2018;4(5):001-4.doi: 10.19080/GJPPS.2018.04.555647
Shivalingam MR, Balasubramanian AR, Ramalingam KO. Formulation and evaluation of transdermal patches of pantoprazole sodium. Int J App Pharm. 2021 Sep 7;13(5):287-91.DOI: https://dx.doi.org/10.22159/ijap.2021v13i5.42175.
Ananthalakshmi D, Sravya E, Rakesh K, Aishwarya P, Sivaparvathi S, Prasanna VK, Satyanarayana T. Formulation And Evaluation Of Transdermal Patches Of Metoprolol Succinate. World Journal of Pharmaceutical Research. 2023; 12(4):1503-1514.DOI: 10.20959/wjpr20234-27368
https://www.businessresearchinsights.com/market-reports/RXB-market-108902#:~:text=The%20global%20RXB%20market%20size,10.19%25%20during%20the%20forecast%20period (Accessed on 05-05-2024).
Nadendla, Rama andJuluri, Satyanarayana & Doppalapudi, Sai & Pyda, Venkata &Tadiboina, Avinash & Addanki, Vishnuvarddhaan& Kalluri, Sriharshavardhan. (2021). Physico-Chemical Characterization of RXB and Compatibility Studies with Its Pharmaceutical Excipients: Life Sciences-Pharma. International Journal of Life Science and Pharma Research. 2021;11(3):25-32.10.22376/ijpbs/lpr.2021.11.3.P25-P32.
Published
How to Cite
Issue
Section
Copyright (c) 2024 RAMA RAO NADENDLA
This work is licensed under a Creative Commons Attribution 4.0 International License.